Endocrine system
Brian J Pollard, Gareth Kitchen in Handbook of Clinical Anaesthesia, 2017
Primary adrenocortical insufficiency is the inability of the adrenal cortex to secrete cortisol and aldosterone due to destruction of the gland. Classical Addison’s disease is caused by an autoimmune process and is important because it is frequently part of the autoimmune polyendocrine syndrome, type 2 (APS-II) that includes Hashimoto thyroiditis hypothyroidism and type I diabetes mellitus. Patients should therefore undergo appropriate endocrine screening. Other causes of primary adrenocortical insufficiency are given in Table 6.2.
Laboratory evaluation of parathyroid gland function
Pallavi Iyer, Herbert Chen in Thyroid and Parathyroid Disorders in Children, 2020
After careful historical review and physical examinations, the evaluation of disorders of calcium homeostasis begins with measurements of serum concentrations of total calcium and Ca2+, phosphate, creatinine, and intact PTH1-84 (7). Depending upon whether the problem one is attempting to solve is associated with hypocalcemia, hypercalcemia, or eucalcemia, further evaluation is undertaken. Thus, in the absence of intestinal malabsorption or severe compromise of renal function, the hypocalcemic, hyperphosphatemic child with reproducibly low or unmeasurable serum PTH concentrations most likely has hypoparathyroidism—prompting a search for the cause of parathyroid gland dysfunction such as congenital aplasia or hypoplasia of the parathyroid glands (e.g., the DiGeorge syndrome due to aberrant differentiation of structures derived from the third and fourth branchial pouches; variants of GATA3, NEBL, TBCE, and CHD7 may also be associated with abnormal differentiation of the parathyroid glands, while variants of PTH may result in abnormal synthesis of its product), a destructive autoimmune process affecting the parathyroid glands (isolated or associated with autoimmune polyendocrine syndrome type 1 related to a variant of AIRE), or a post-cervical surgical insult. Gain-of-function variants of CASR, the gene encoding the calcium-sensing receptor, are also associated with suppressed synthesis/secretion of PTH and resultant hypocalcemia. If serum PTH concentrations are elevated in the hypocalcemic, hyperphosphatemic patient, then abnormalities of PTH function (pseudohypoparathyroidism) should be evaluated including those due to variants of GNAS1 encoding the alpha subunit of the guanine nucleotide binding protein. In the hypocalcemic subject with elevated serum concentrations of PTH but normal or low serum levels of phosphate, intestinal absorption of calcium may be extremely low due to decreased intake of this cation or its impaired intestinal absorption due to vitamin D deficiency (identified by subnormal serum concentrations of calcidiol) or an abnormality of vitamin D metabolism and the production of calcitriol. Severe renal impairment may also hinder the synthesis of calcitriol. In the presence of high serum levels of calcitriol, an abnormality of the vitamin D receptor should be considered. Deficiency of magnesium stores may be associated with subnormal secretion of PTH and consequent hypocalcemia. Please see Table 9.1 for an evaluation of a hypocalcemic child, correlating laboratory findings with clinical conditions.
Genetic syndromes and autoimmunity: what do we know? Focus on Down and Turner syndrome
Published in Expert Review of Clinical Immunology, 2023
Alessandra Li Pomi, Malgorzata Wasniewska
The most important genetic locus associated with increased susceptibility to autoimmunity is the HLA locus, which contains genes involved in presenting antigens to immune cells. In the minority of cases, ADs are monogenic, deriving from defects in a single gene with highly penetrant mutations that disrupt essential mechanisms of central and peripheral immune tolerance. For example, Autoimmune Polyendocrine Syndrome Type 1 (APS-1) is defined by the presence of at least two of three clinical features: muco-cutaneous candidiasis, Addison disease and hypoparathyroidism. These conditions can be associated with other organ-specific autoimmune diseases (such as thyroiditis, type 1 diabetes, vitiligo, autoimmune gastritis, etc.). APS-1 is caused by AIRE gene deficiency, which plays a key role in establishing tolerance to self-antigens [2]. Studies to date have concluded that autoimmune diseases are probably caused by an inflammatory response by self-antigen-specific T cells, but the exact pathogenetic mechanisms are still unknown.
Immune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attention
Published in Expert Opinion on Drug Safety, 2022
Djordje S. Popovic, Theocharis Koufakis, Bojan Kovacevic, Manfredi Rizzo, Nikolaos Papanas
Nonetheless, given that ICs are vital for the preservation of immunological self-tolerance, their inhibition may trigger adverse events of autoimmune origin [4]. Indeed, endocrine complications (hypophysitis, thyroid dysfunction, diabetes mellitus (DM), primary adrenal insufficiency, and autoimmune polyendocrine syndrome type 2) are among the most common adverse effects of ICIs therapy [4], and their development may also be a predictor of response to ICIs therapy [5,6]. New-onset DM is one of the potential immune-related adverse events associated with ICIs administration. It usually resembles type 1 DM (T1DM) in its pathophysiology and clinical presentation, although some individuals may present with features of type 2 DM or with worsening hyperglycemia in case of preexistent abnormal glucose tolerance or previously diagnosed DM [7].
Delay in the Diagnosis of APECED: A Case Report and Review of Literature from Iran
Published in Immunological Investigations, 2020
Mahnaz Jamee, Seyed Alireza Mahdaviani, Davood Mansouri, Gholamreza Azizi, Nematollah Joneidi, Hosseinali Ghaffaripour, Shabnam Eskandarzade, Mehdi Ghaini, Majid Marjani, Afshin Moniri, Mélanie Migaud, Jl Casanova, Anne Puel, Aliakbar Velayati
To the best of our knowledge, to date, 39 other Iranian APECED cases have been reported (Buber et al. 2008; Dastjerdi et al. 2007; Mohammadpour and Javadi 2006, Pollak et al. 2009; Sajjadi-Jazi et al. 2019; Seifi-Alan et al. 2016; Vakili et al. 2014; Zlotogora and Shapiro 1992), mostly diagnosed based on the clinical findings. We reviewed the literature published from 1992 to date on a series of 39 APECED patients including the present case report. The literature search and evaluation were performed using “APECED”, “APS1”, “Autoimmune polyendocrine syndrome type 1” “Autoimmune polyendocrinopathy, candidiasis and ectodermal dystrophy” and “Iran” keywords. In addition, multi-center studies were checked for Iranian cases and reference lists of major reviews and case series were manually searched for additional studies. Table S2 represents the summary of clinical and molecular findings of reported Iranian cases with APECED.
Related Knowledge Centers
- Adrenal Insufficiency
- Autoimmune Polyendocrine Syndrome Type 1
- Autoimmunity
- Candidiasis
- Hypogonadism
- Endocrine System
- Vitiligo
- Rare Disease
- Dominance
- Hypoparathyroidism